Holly Springs, North Carolina, is attracting pharmaceutical companies with features that once characterized Switzerland, transforming North Carolina from America's poorest state to its most business-friendly.

China has given its approval for an innovative breast cancer therapy developed jointly by pharmaceutical companies Daiichi Sankyo and AstraZeneca, expanding treatment options for patients.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, which is expanding Zepbound access, along with Novo Nordisk and Novartis.

Pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece by the independent international organization Top Employers Institute for the fourth consecutive year.

Chinese contract drug makers – including WuXi AppTec, WuXi Biologics and WuXi XDC – face a less certain long-term revenue outlook as US pharmaceutical companies bring production in-house and reconfigure supply chains amid rising US-China tensions. While near-term earnings remained largely locked in, visibility beyond that was limited, according to Cui Cui, head of healthcare research for Asia at Jefferies. “Earnings visibility for 2026 and 2027 is still very strong – revenue momentum is large...

The director of the newspaper Página Um has been acquitted of defamation charges, with the court deeming the accusation 'totally unfounded' in a case stemming from articles about alleged financial links between doctors and pharmaceutical companies during the Covid-19 pandemic.

Subscribe to the "Kapital Zdrave" newsletter here to follow the most current processes in the health sector.

Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.

Indian pharmaceutical companies Eris Lifesciences and Natco Pharma have entered into an agreement concerning the drug Semaglutide.

Multiple biotech and pharmaceutical companies, including Legend Biotech, Corcept Therapeutics, and Ultragenyx, have released updates on their drug pipelines, clinical trial data, and regulatory interactions, impacting market outlook.

Poolbeg Pharma's CEO stated that the recent patent win for POLB-001 significantly strengthens the company's potential for partnerships with major pharmaceutical companies.

FBI Director Kash Patel announced a major crackdown, 'Operation Box Cutter,' which has led to the indictment of Chinese pharmaceutical companies for allegedly supplying fentanyl precursors to the Gulf cartel.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, Novo Nordisk, and Novartis.

Startups are actively working on commercial space stations, envisioning opportunities for pharmaceutical companies and wealthy tourists following the International Space Station's retirement in 2030.

For the fourth consecutive year, pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece by the independent international organization Top Employers Institute.

Mainland Chinese investors can now buy shares in more than a dozen newly added Hong Kong-listed biotech and pharmaceutical companies after a reshuffle of the Stock Connect southbound trading list took effect on Monday, reflecting the sector’s growing role on the international stage. Foreign capital, however, remained cautious, analysts said. “Mainland buyers have been the main force behind the latest healthcare rally. They tend to chase smaller-cap names where a tight free float makes it easi...

A report highlights notable healthcare headlines for the week, focusing on developments related to pharmaceutical companies Viatris, Novo Nordisk, and Gilead Sciences.

The European market is experiencing an influx of medicines produced in Asia, particularly from China, which poses a significant threat to drug security and creates growing competition for European pharmaceutical companies, including those in Poland.

The FDA has released new guidance aimed at speeding up the development process for pharmaceutical companies working on treatments for rare diseases, potentially benefiting the sector.

Cross-border outlicensing activities by Chinese biotech firms reached a record US$60 billion in the first quarter of 2026, driven by multinational pharmaceutical companies' growing interest in the country's promising drug candidates.

Indian pharmaceutical companies are pursuing an aggressive strategy to enter European markets with generic products, capitalizing on Europe's push for greater autonomy in drug supply, according to Aneta Grzegorzewska of Ged.

An official from the Federal Trade Commission (FTC) stated that the agency is monitoring how major pharmaceutical companies are reacting to upcoming patent expirations.

Swiss-based Syngenta announced plans to build a new $120 million agricultural science center in the UK, an investment that contrasts with pharmaceutical companies withdrawing funding from British research facilities.

International pharmaceutical companies are expanding their operations and presence in the United States, a strategic move influenced by the looming threat of tariffs.

Hong Kong-listed mainland Chinese pharmaceutical companies are projected to achieve full-year profits, driven by increasing drug sales and successful out-licensing deals with global partners.

Poland's Ministry of Health is advocating for drug sovereignty by supporting the refunding of domestically produced medicines and offering incentives to pharmaceutical companies that relocate production to Poland, aiming to enhance drug security.

Delays in pricing and reimbursement processes continue to negatively affect the revenue streams of biopharmaceutical companies.